Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: June 29, 2024
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2023
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: May 30, 2021
Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial.
Journal: NPJ breast cancer
Published: January 07, 2020
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.
Journal: NPJ breast cancer
Published: December 21, 2016
Neoadjuvant as Future for Drug Development in Breast Cancer--Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 06, 2016
Showing 1-7 of 7
Last Updated: 09/26/2026